Departed
Marc Wilson
Other
CRNX ·
Crinetics Pharmaceuticals, Inc.
pursuant to which Mr. Wilson resigned as an employee of the Company, effective April 1, 2025
Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 6951–7000 of 75459
pursuant to which Mr. Wilson resigned as an employee of the Company, effective April 1, 2025
Each of Ramesh Gopalakrishnan and Jeffrey S. McCreary notified the Board of Directors (the “Board”) of Benchmark Electronics, Inc. (the “Company”) on April 2, 2025 and April 3, 2025, respectively, of his intent not to stand for re-election at the Company’s 2025 annual meeting of shareholders to be held on May 14, 2025 (the “Meeting”) upon the expiration of his term.
Each of Ramesh Gopalakrishnan and Jeffrey S. McCreary notified the Board of Directors (the “Board”) of Benchmark Electronics, Inc. (the “Company”) on April 2, 2025 and April 3, 2025, respectively, of his intent not to stand for re-election at the Company’s 2025 annual meeting of shareholders to be held on May 14, 2025 (the “Meeting”) upon the expiration of his term.
the Board has nominated Glynis A. Bryan, retired Chief Financial Officer of Insight Enterprises, Inc. (NASDAQ:NSIT), for election to the Board at the Meeting.
On April 2, 2025, the Company and its President, L. Jay Cross, mutually agreed not to renew Mr. Cross’ employment agreement upon the expiration of its current term on December 1, 2025, which shall be treated as a non-renewal by the Company under his employment agreement.
As of the Effective Time, all directors of the Company serving as of immediately prior to the Effective Time, consisting of James B. Miller, Jr., Allan Dow, W. Dennis Hogue, Matthew G. McKenna, Celena Matlock, Thomas L. Newberry, V., Lizanne Thomas, and Nicole Wu, resigned from the board of directors of the Company including any committees thereof on which they served.
As of the Effective Time, all directors of the Company serving as of immediately prior to the Effective Time, consisting of James B. Miller, Jr., Allan Dow, W. Dennis Hogue, Matthew G. McKenna, Celena Matlock, Thomas L. Newberry, V., Lizanne Thomas, and Nicole Wu, resigned from the board of directors of the Company including any committees thereof on which they served.
As of the Effective Time, all directors of the Company serving as of immediately prior to the Effective Time, consisting of James B. Miller, Jr., Allan Dow, W. Dennis Hogue, Matthew G. McKenna, Celena Matlock, Thomas L. Newberry, V., Lizanne Thomas, and Nicole Wu, resigned from the board of directors of the Company including any committees thereof on which they served.
the directors of Merger Sub immediately prior to the Effective Time, which consisted of Telukutla Venkata Nasara Reddy and Katherine Dunn, became the directors of the surviving corporation.
As of the Effective Time, all directors of the Company serving as of immediately prior to the Effective Time, consisting of James B. Miller, Jr., Allan Dow, W. Dennis Hogue, Matthew G. McKenna, Celena Matlock, Thomas L. Newberry, V., Lizanne Thomas, and Nicole Wu, resigned from the board of directors of the Company including any committees thereof on which they served.
As of the Effective Time, all directors of the Company serving as of immediately prior to the Effective Time, consisting of James B. Miller, Jr., Allan Dow, W. Dennis Hogue, Matthew G. McKenna, Celena Matlock, Thomas L. Newberry, V., Lizanne Thomas, and Nicole Wu, resigned from the board of directors of the Company including any committees thereof on which they served.
the following persons became officers of the Company: Telukutla Venkata Nasara Reddy, Brad Debold and Katherine Dunn.
the directors of Merger Sub immediately prior to the Effective Time, which consisted of Telukutla Venkata Nasara Reddy and Katherine Dunn, became the directors of the surviving corporation.
As of the Effective Time, all directors of the Company serving as of immediately prior to the Effective Time, consisting of James B. Miller, Jr., Allan Dow, W. Dennis Hogue, Matthew G. McKenna, Celena Matlock, Thomas L. Newberry, V., Lizanne Thomas, and Nicole Wu, resigned from the board of directors of the Company including any committees thereof on which they served.
the following persons became officers of the Company: Telukutla Venkata Nasara Reddy, Brad Debold and Katherine Dunn.
As of the Effective Time, all directors of the Company serving as of immediately prior to the Effective Time, consisting of James B. Miller, Jr., Allan Dow, W. Dennis Hogue, Matthew G. McKenna, Celena Matlock, Thomas L. Newberry, V., Lizanne Thomas, and Nicole Wu, resigned from the board of directors of the Company including any committees thereof on which they served.
As of the Effective Time, all directors of the Company serving as of immediately prior to the Effective Time, consisting of James B. Miller, Jr., Allan Dow, W. Dennis Hogue, Matthew G. McKenna, Celena Matlock, Thomas L. Newberry, V., Lizanne Thomas, and Nicole Wu, resigned from the board of directors of the Company including any committees thereof on which they served.
the following persons became officers of the Company: Telukutla Venkata Nasara Reddy, Brad Debold and Katherine Dunn.
increased the size of the Board from eight to nine directors and appointed Wayde McMillan as a director of the Company, effective April 4, 2025.
appointed Wayde McMillan as a director of the Company, effective April 4, 2025.
the Company appointed Peter J. Weiler to serve as the Company’s Chief Financial Officer, effective May 1, 2025
Stephen Lemieux, Chief Financial Officer of Edesa Biotech, Inc. (the “Company”), notified the Company of his intention to resign from his position and responsibilities as Chief Financial Officer, effective May 1, 2025, to pursue another professional opportunity.
On April 2, 2025, Atif Rafiq, a member of the Board of Directors (the “Board”) of Flutter Entertainment plc (the “Company”), notified the Board of his decision to not stand for re-election at the end of his current term at the Company’s 2025 Annual General Meeting of Shareholders scheduled to be held on June 5, 2025, due to Mr. Rafiq’s other time commitments.
On April 3, 2025, upon the recommendation of the Nominating and Corporate Governance Committee of the Board of Directors (the “Board”) of Kalaris Therapeutics, Inc. (the “Company”), the Board elected Leone Patterson to serve as a member of the Board, effective immediately.
On March 31, 2025, John J. Cronin, Jr. submitted his resignation from his role as Chief Financial Officer of Mastech Digital, Inc. (the “Company”), effective as of April 14, 2025 (the “Effective Date”).
On March 31, 2025, the Board of Directors of the Company (the “Board”) appointed Kannan Sugantharaman as the Company’s Chief Financial Officer and Chief Operations Officer, effective as of the Effective Date.
On April 4, 2025, David G. Infuso was appointed as the Chief Accounting Officer and the principal accounting officer of MP Materials Corp. (the “Company”).
On March 31, 2025, G. Christopher McGibbon notified the board of directors of Nuveen Global Cities REIT, Inc. (the “Company”) of his resignation from his position as Co-President of the Company.
on April 3, 2025, the Company’s board of directors appointed Chad W. Phillips as Co-President.
On April 3, 2025, Thomas J. Seifert and George H. “Woody” Young III, members of the Board of Directors (the “Board”) of Wolfspeed, Inc. (the “Company”), each notified the Company of his decision to resign from the Board, effective as of April 3, 2025.
On April 3, 2025, Thomas J. Seifert and George H. “Woody” Young III, members of the Board of Directors (the “Board”) of Wolfspeed, Inc. (the “Company”), each notified the Company of his decision to resign from the Board, effective as of April 3, 2025.
On April 2, 2025, Anne De Greef-Safft informed Ambarella, Inc. (the “Company”) that she will not stand for re-election to the Board of Directors at the Company’s 2025 annual meeting of shareholders, when her term will expire.
On and effective March 31, 2025, Robert E. Flint and Colin Kwak were appointed to the Board of Directors
On and effective March 31, 2025, Ted Papapostolou resigned from the Board and from its Compensation Committee, Nominating and Corporate Governance Committee, and Special Committee.
Mr. Flint was appointed as Chairperson of the Board and to the Board’s Special Committee
On April 3, 2025, the Company appointed Gary Delanois to serve as the Company’s Chief Executive Officer.
Effective on that same date, Raymond Stachowiak ceased to serve in the role of Chief Executive Officer, however, he will continue to serve as the Company’s Executive Chairman of the Board and continue to perform the function of the Company’s principal executive officer.
Effective April 2, 2025, Mr. Monty Kness, age 43, was appointed to serve as the Chief Operating Officer.
William Avery, age 77, is stepping down from his interim position as President effective April 2, 2025, and continuing his full- time position as General Counsel.
Effective April 2, 2025, Michael B. Croswell Jr., age 54, was appointed to serve as President and will continue in his role as Chief Financial Officer.
On March 31, 2025, the Company appointed Saleh Sagr, age 55, as President.
Concurrent with this announcement, the Company has appointed Saleh Sagr as President, with Mr. Mansfield remaining as the Chief Executive Officer.
On April 2, 2025, Brigid Bonner, a member of the Nominating and Governance Committee and Chair of the Compensation Committee, informed the Board of Directors (the “Board”) of Workiva Inc. (the “Company”) of her decision not to stand for re-election as a Class II director of the Board when her current term expires at the Company’s 2025 annual meeting of the stockholders (the “Annual Meeting”).
On April 1, 2025, Manjula Talreja resigned from the board of directors (the “ Board ”) of Sunrun Inc. (the “ Company ”) and her role as a member of the Audit Committee and Nominating, Governance, and Sustainability (“ NGS ”) Committee, effective as of April 4, 2025 (the “ Effective Date ”).
did approve and authorize the appointment of Michael Rountree as Secretary of the Company
On April 2, 2025, the Board of Directors approved, authorized and accepted the resignation of S Randall Oveson as Secretary of the Company
On April 1, 2025, Upland Software, Inc. (the “Company”) eliminated the Chief Sales Officer (“CSO”) position and terminated Oliver Yates, the Company’s CSO, without cause, effective immediately.
Mr. Wright will continue to serve in his current role at the Company until November 15, 2025, at which time Mr. Wright will also be promoted to Executive Vice President of the Company.
Robert Wright, the Senior Vice President, Deputy Chief Financial Officer, and Chief Accounting Officer of the Company and the Partnership, will serve in addition as Executive Vice President and Chief Financial Officer of the Partnership, effective April 1, 2025.
On April 1, 2025, Vincent Donargo notified Calumet, Inc. (the “Company”) of his resignation as the Company’s Chief Accounting Officer and principal accounting officer, effective April 15, 2025 (the “Effective Date”).
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.